Personalized cancer vaccine is safe, shows potential benefit against cancer

Eurek Alert

Center

High Factuality

Other: American Association for the Advancement of Science

Personalized cancer vaccine is safe, shows potential benefit against cancer

A personalized cancer vaccine developed with the help of a Mount Sinai computational platform raised no safety concerns and showed potential benefit in patients with different cancers, including lung and bladder, that have a high risk of recurrence, according to results from an investigator-initiated phase I clinical trial presented during the virtual American Association for Cancer Research (AACR) Annual Meeting 2021, held April 10-15.